Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycerol Phenylbutyrate in Pyruvate Dehydrogenase Deficiency (PDH)
NCT06887777Phase 2Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glycerol phenylbutyrate in Pyruvate dehydrogenase complex deficiency (PDCD), sponsored by Assistance publique - Hôpitaux de Paris. Started Oct 2025; status: recruiting.
02
Drugs
glycerol phenylbutyrate
03
Conditions
Pyruvate dehydrogenase complex deficiency (PDCD)
Beyond the preview
Go deeper on NCT06887777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06887777.